why choose us

First received: August 17, 2023

Clinical Trial: A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Geographic Atrophy

Study Type: INTERVENTIONAL


Official Title: Safety, Tolerability, and Pharmacokinetics of Intravitreal Single Rising Doses and Multiple Doses of BI 771716 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration (Open L

Brief Summary: This study is open to adults with geographic atrophy, an advanced form of age-related macular degeneration.People can join the study if they are at least 50 years old.The purpose of this study is to find out how well different doses of a medicine called BI 771716 are tolerated.This study has 2 parts.Part 1 of the study takes about 3 months.In this part, participants receive 1 injection of BI 771716 directly into one of the eyes affected by geographic atrophy.Part 2 of the study takes about 4 months.In this part,…

Read more